A novel risk score to stratify severity of Crohn's disease hospitalizations
- PMID: 20216534
- DOI: 10.1038/ajg.2010.105
A novel risk score to stratify severity of Crohn's disease hospitalizations
Abstract
Objectives: Crohn's disease (CD) is a lifelong relapsing-remitting disease often requiring health-care contact, hospitalization, or surgery. General comorbidity indices were developed to predict mortality, which is rare in this population. There are limited tools to stratify these hospitalizations by severity.
Methods: We used data obtained from the Nationwide Inpatient Sample 2004 to identify all CD-related hospitalizations using discharge diagnosis codes (International Classification of Diseases, 9th edition, Clinical Modification, ICD-9-CM, 555.x). Independent predictors on multivariate regression were identified and used to construct a quantitative risk score to predict severe hospitalizations (defined as requiring nonelective bowel surgery or hospitalization longer than 7 days). The performance of our risk score was compared with the Elixhauser and Charlson comorbidity indices, and validated in an independent sample of CD hospitalizations from 2007.
Results: Our final study cohort consisted of 25,938 discharges, among which 6,169 were determined to be severe hospitalizations (23.8%). Independent predictors of disease severity included disease phenotype, anemia, malnutrition, and requirement for blood transfusion or total parenteral nutrition, as well as Clostridium difficile infection, admission to a teaching hospital, or inter-hospital transfer. The cumulative risk score ranged from 0 to 13 points, with scores >or=5 being considered to be of greater severity. A total of 15,330 (59.1%), 9,060 (34.9%), and 1,548 (6.0%) discharges were classified as being of low, intermediate, and high risk, respectively. An intermediate (odds ratio (OR) 2.63, 95% confidence interval (CI): 2.47-2.80) or high-risk score (OR 13.62, 95% CI: 12.12-15.33) was associated with a significantly higher adjusted risk of severe hospitalization.
Conclusions: Using administrative data, we propose a simple quantitative risk score to measure the severity of CD hospitalizations.
Comment in
-
Administrative database studies in IBD: a cautionary tale.Am J Gastroenterol. 2010 Aug;105(8):1808-10. doi: 10.1038/ajg.2010.232. Am J Gastroenterol. 2010. PMID: 20686467
Similar articles
-
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.Am J Gastroenterol. 2008 Jun;103(6):1443-50. doi: 10.1111/j.1572-0241.2007.01780.x. Epub 2008 May 29. Am J Gastroenterol. 2008. PMID: 18513271
-
Administrative database studies in IBD: a cautionary tale.Am J Gastroenterol. 2010 Aug;105(8):1808-10. doi: 10.1038/ajg.2010.232. Am J Gastroenterol. 2010. PMID: 20686467
-
Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis.Pediatrics. 2007 Mar;119(3):487-94. doi: 10.1542/peds.2006-2353. Pediatrics. 2007. PMID: 17332201
-
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.Am J Gastroenterol. 2012 Dec;107(12):1770-6. doi: 10.1038/ajg.2012.117. Am J Gastroenterol. 2012. PMID: 23211844
-
Measurement properties of comorbidity indices in maternal health research: a systematic review.BMC Pregnancy Childbirth. 2017 Nov 13;17(1):372. doi: 10.1186/s12884-017-1558-3. BMC Pregnancy Childbirth. 2017. PMID: 29132349 Free PMC article. Review.
Cited by
-
Outcomes of Continuation vs Discontinuation of Adalimumab Therapy During Third Trimester of Pregnancy in Inflammatory Bowel Disease.Gastro Hep Adv. 2022 May 16;1(5):785-791. doi: 10.1016/j.gastha.2022.04.009. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131851 Free PMC article.
-
Weight loss from diagnosis of Crohn's disease to one year post-diagnosis results in earlier surgery.Sci Rep. 2023 Nov 30;13(1):21101. doi: 10.1038/s41598-023-48474-x. Sci Rep. 2023. PMID: 38036713 Free PMC article.
-
Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease.Nutrients. 2023 Aug 31;15(17):3824. doi: 10.3390/nu15173824. Nutrients. 2023. PMID: 37686856 Free PMC article. Review.
-
Cytomegalovirus Infection Is Associated With Adverse Outcomes Among Hospitalized Pediatric Patients With Inflammatory Bowel Disease.Gastroenterology Res. 2023 Feb;16(1):1-8. doi: 10.14740/gr1588. Epub 2023 Feb 28. Gastroenterology Res. 2023. PMID: 36895701 Free PMC article.
-
Rising Burden of Psychiatric and Behavioral Disorders and Their Adverse Impact on Health Care Expenditure in Hospitalized Pediatric Patients with Inflammatory Bowel Disease.Pediatr Gastroenterol Hepatol Nutr. 2023 Jan;26(1):23-33. doi: 10.5223/pghn.2023.26.1.23. Epub 2023 Jan 10. Pediatr Gastroenterol Hepatol Nutr. 2023. PMID: 36816440 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
